Rubio A - Search Results

1

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.

Gallego O, de Mendoza C, Pérez-Elías MJ, Guardiola JM, Pedreira J, Dalmau D, Gónzalez J, Moreno A, Arribas JR, Rubio A, García-Arata I, Leal M, Domingo P, Soriano V. Gallego O, et al. Among authors: rubio a. AIDS. 2001 Sep 7;15(13):1701-6. doi: 10.1097/00002030-200109070-00014. AIDS. 2001. PMID: 11546946

2

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.

Gómez-Cano M, Rubio A, Puig T, Pérez-Olmeda M, Ruiz L, Soriano V, Pineda JA, Zamora L, Xaus N, Clotet B, Leal M. Gómez-Cano M, et al. Among authors: rubio a. AIDS. 1998 Jun 18;12(9):1015-20. AIDS. 1998. PMID: 9662197

3

Efficiency of drug resistance genotypic tests in specimens with low HIV viral load.

Gómez-Cano M, Rubio A, Ruiz L, Pérez-Olmeda M, Leal M, Clotet B, Soriano V. Gómez-Cano M, et al. Among authors: rubio a. Antivir Ther. 1999;4(2):123-4. Antivir Ther. 1999. PMID: 10682158

4

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group.

Puig T, Pérez-Olmeda M, Rubio A, Ruiz L, Briones C, Franco JM, Gómez-Cano M, Stuyver L, Zamora L, Alvarez C, Leal M, Clotet B, Soriano V. Puig T, et al. Among authors: rubio a. AIDS. 2000 Apr 14;14(6):727-32. doi: 10.1097/00002030-200004140-00012. AIDS. 2000. PMID: 10807196

5

Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.

Pérez-Olmeda M, Del Romero J, Rubio A, Ruiz L, Rodríguez C, Leal M, Clotet B, Soriano V. Pérez-Olmeda M, et al. Among authors: rubio a. J Med Virol. 2001 Feb;63(2):85-7. J Med Virol. 2001. PMID: 11170042

6

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.

Gallego O, Ruiz L, Vallejo A, Ferrer E, Rubio A, Clotet B, Leal M, Soriano V; ERASE-3 Group. Gallego O, et al. Among authors: rubio a. AIDS. 2001 Sep 28;15(14):1894-6. doi: 10.1097/00002030-200109280-00025. AIDS. 2001. PMID: 11579258

7

Short-term evolution of HIV-1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudine.

Rubio A, Leal M, Rey C, Pineda JA, Sanchez-Quijano A, Lissen E. Rubio A, et al. AIDS. 1998 Mar 5;12(4):395-8. doi: 10.1097/00002030-199804000-00008. AIDS. 1998. PMID: 9520169

8

Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimens.

Pèrez-Olmeda M, Rubio A, Puig T, Gômez-Cano M, Ruiz L, Leal M, Clotet B, Soriano V. Pèrez-Olmeda M, et al. Among authors: rubio a. Antivir Ther. 1999;4(3):179-81. Antivir Ther. 1999. PMID: 12731758

9

Presence of genotypic resistance in nucleoside analogue-treated HIV-1-infected patients with undetectable viral load.

Rubio A, Gómez-Cano M, Puig T, Leal M, Pérez-Olmeda M, Ruiz L, Clotet B, Rey C, Zamora L, Xaus N, Soriano V. Rubio A, et al. Antivir Ther. 1999;4(1):45-9. Antivir Ther. 1999. PMID: 10682128

10

Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996.

Rubio A, Leal M, Pineda JA, Caruz A, Luque F, Rey C, Sanchez-Quijano A, Lissen E. Rubio A, et al. AIDS. 1997 Jul 15;11(9):1184-6. doi: 10.1097/00002030-199709000-00016. AIDS. 1997. PMID: 9233468 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,065 results

Search Page

Filters